Kane Biotech Inc (TSXV:KNE)
C$ 0.13 0 (0%) Market Cap: 17.23 Mil Enterprise Value: 18.60 Mil PE Ratio: 4.33 PB Ratio: 0 GF Score: 37/100

Q3 2021 Kane Biotech Inc Earnings Call Transcript

Nov 16, 2021 / 09:30PM GMT
Release Date Price: C$0.16
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Kane Biotech Q3 2021 financial results. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time.(Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Mr. Lorne Gorber, Head of Investor Relations. Sir, you may begin.

Lorne Gorber
Kane Biotech Inc. - Investor Relations

Thank you, Mel. Good afternoon, everyone. We're delighted to have you join us today for Kane Biotech's Q3 2021 results conference call. With me to review the financial and operating results for the third quarter ended September 30, 2021, are Kane's CEO, Marc Edwards, and its CFO, Ray Dupuis. Following prepared remarks, we will open the lines and take your questions.

Before handing it over to Ray, let me caution you that our comments and discussion will include forward-looking information within the meaning of applicable securities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot